Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-20-001023
Filing Date
2020-10-02
Accepted
2020-10-02 16:32:27
Documents
1
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 pfenex_fm4sept302020.html 4  
1 pfenex_fm4sept302020.xml 4 4403
  Complete submission text file 0000905718-20-001023.txt   5925
Mailing Address 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address 10790 ROSELLE STREET SAN DIEGO CA 92121 858-352-4400
Pfenex Inc. (Issuer) CIK: 0001478121 (see all company filings)

EIN.: 271356759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165
Business Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165 212-446-2465
Newtyn Management, LLC (Reporting) CIK: 0001569241 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36540 | Film No.: 201220493